NCT01475981View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics Study Assessing Ascending Single Oral JTK-853 Doses in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

70

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions

Healthy

Interventions

DRUG

JTK-853 or Placebo

Tablets, single dose, fasted, fed or high-fat fed condition

Trial Locations (1)

78744

PPD, Phase I Clinic, Austin

Sponsors

Lead Sponsor

Akros Pharma Inc.

All Listed Sponsors

lead

Akros Pharma Inc.

INDUSTRY

NCT01475981 - Safety, Tolerability and Pharmacokinetics Study Assessing Ascending Single Oral JTK-853 Doses in Healthy Subjects | Biotech Hunter | Biotech Hunter